Environmental sustainability in asthma: reducing carbon footprint and medication wastage
ICS-LABA MDIs are the predominant source of inhaler-related carbon footprint, with additional contribution from excessive dispensation of inhalers.
Authors
- Shao Wei Lam (ORCID: https://orcid.org/0000-0002-0898-5858)
- Ishita Goel
- Mariko Siyue Koh (ORCID: https://orcid.org/0000-0002-1230-0129)
- Ming Ren Toh (ORCID: https://orcid.org/0000-0002-7019-9743)
- Jun Tian Wu
- Ngiap Chuan Tan (ORCID: https://orcid.org/0000-0002-5946-1149)
- Chian Min Loo
- Kathy A. Low (ORCID: https://orcid.org/0000-0001-6787-3701)
- Susan Ang (ORCID: https://orcid.org/0000-0003-0180-584X)
- Chun Fan Lee (ORCID: https://orcid.org/0000-0001-5601-3167)
- David Bruce Matchar (ORCID: https://orcid.org/0000-0003-3020-2108)
- Vivian Tan
- Marcus Eng Hock Ong (ORCID: https://orcid.org/0000-0001-7874-7612)
- Ting Chan (ORCID: https://orcid.org/0000-0002-8707-4592)
- Kheng Yong Ong (ORCID: https://orcid.org/0000-0002-4272-4993)
- Gerald Xuan Zhong Ng
Institutions
- Nanyang Technological University (SG)
- Singapore General Hospital (SG)
- SingHealth Polyclinics (SG)
- Duke-NUS Medical School (SG)
- MOH Holdings (SG)
Publication Details
- Journal
- Allergy Asthma and Clinical Immunology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1186/s13223-025-00988-x
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline
- Singapore General Hospital